Combining NSAIDs and TNFi may reduce radiographic progression in ankylosing spondylitis

The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients with ankylosing spondylitis (AS) taking tumour necrosis factor (TNF) inhibitors, the addition of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with significantly less radiographic progression in a dose-related manner at four years.

Go to Source

(Visited 3 times, 1 visits today)

Site Footer

Sliding Sidebar